Hindbrain catecholamine regulation of ventromedial hypothalamic nucleus glycogen metabolism during acute versus recurring insulin-induced hypoglycemia in male versus female rat.
6-hydroxydopamine
Glycogen phosphorylase
Glycogen synthase
Recurrent insulin-induced hypoglycemia
Sex differences
Ventromedial hypothalamic nucleus
Journal
Endocrine and metabolic science
ISSN: 2666-3961
Titre abrégé: Endocr Metab Sci
Pays: England
ID NLM: 101776826
Informations de publication
Date de publication:
30 Jun 2021
30 Jun 2021
Historique:
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
18
5
2021
Statut:
ppublish
Résumé
Ventromedial hypothalamic nucleus (VMN) glycogen metabolism affects local glucoregulatory signaling. The hindbrain metabolic-sensitive catecholamine (CA) neurotransmitter norepinephrine controls VMN glycogen phosphorylase (GP)-muscle (GPmm) and -brain (GPbb) type expression in male rats. Present studies addressed the premise that CA regulation of hypoglycemic patterns of VMN glycogen metabolic enzyme protein expression is sex-dimorphic, and that this signal is responsible for sex differences in acclimation of these profiles to recurrent insulin-induced hypoglycemia (RIIH). VMN tissue was acquired by micropunch-dissection from male and female rats pretreated by caudal fourth ventricular administration of the CA neurotoxin 6-hydroxydopamine (6OHDA) before single or serial insulin injection. 6-OHDA averted acute hypoglycemic inhibition of VMN glycogen synthase (GS) and augmentation of GPmm and GPbb protein expression in males, and prevented GPmm and -bb down-regulation in females. Males recovered from antecedent hypoglycemia (AH) exhibited neurotoxin-preventable diminution of baseline GS profiles, whereas acclimated GPmm and -bb expression in females occurred irrespective of pretreatment. RIIH did not alter VMN GS, GPmm, and GPbb expression in vehicle- or 6-OHDA-pretreated animals of either sex. VMN glycogen content was correspondingly unchanged or increased in males versus females following AH; 6-OHDA augmented glycogen mass in AH-exposed animals of both sexes. RIIH did not alter VMN glycogen accumulation in vehicle-pretreated rats of either sex, but diminished glycogen in neurotoxin-pretreated animals. AH suppresses baseline GS (CA-dependent) or GPmm/GPbb (CA-independent) expression in male and female rats, respectively, which corresponds with unaltered or augmented VMN glycogen content in those sexes. AH-associated loss of sex-distinctive CA-mediated enzyme protein sensitivity to hypoglycemia (male: GS, GPmm, GPbb; female: GPmm, Gpbb) may reflect, in part, VMN target desensitization to noradrenergic input.
Identifiants
pubmed: 33997825
doi: 10.1016/j.endmts.2021.100087
pmc: PMC8114938
mid: NIHMS1698737
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK109382
Pays : United States
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflict of interest.
Références
Front Cell Neurosci. 2013 Apr 10;7:38
pubmed: 23596393
Diabetes Care. 2003 Jun;26(6):1902-12
pubmed: 12766131
Endocrinology. 2004 Apr;145(4):1750-9
pubmed: 14684600
Am J Physiol Regul Integr Comp Physiol. 2014 Apr 1;306(7):R457-69
pubmed: 24381179
Neuroendocrinology. 2001 Jun;73(6):369-77
pubmed: 11408778
Neuroscience. 2014 Oct 10;278:20-30
pubmed: 25084049
Brain Res. 2019 May 15;1711:48-57
pubmed: 30629946
Neuropeptides. 2017 Dec;66:25-35
pubmed: 28823463
Endocrinol Metab Clin North Am. 2010 Sep;39(3):641-54
pubmed: 20723825
J Neurochem. 2004 May;89(3):537-52
pubmed: 15086511
Glia. 2015 Jan;63(1):154-62
pubmed: 25130497
Endocrinology. 2004 Nov;145(11):5322-31
pubmed: 15308614
Neuroscience. 2018 May 21;379:103-114
pubmed: 29534973
Neuroscience. 2015 Apr 30;292:34-45
pubmed: 25701713
J Pharm Biomed Anal. 2020 Jan 30;178:112884
pubmed: 31606560
Endocrinology. 1974 Jun;94(6):1704-8
pubmed: 4857496
Adv Neurobiol. 2019;23:269-309
pubmed: 31667812
Neurochem Res. 2017 Jun;42(6):1629-1635
pubmed: 28083850
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
J Neurosci Res. 2003 Oct 15;74(2):179-83
pubmed: 14515346
J Biol Chem. 2018 May 11;293(19):7099-7107
pubmed: 29483194
Endocrinology. 2008 Apr;149(4):1499-504
pubmed: 18187548
J Neurosci Res. 2003 Apr 1;72(1):25-32
pubmed: 12645076
Acta Neurobiol Exp (Wars). 2020;80(1):57-65
pubmed: 32214275